Phase 2b Trial Results Comparing Aldoxorubicin vs. Doxorubicin in Soft Tissue Sarcoma Patients

www.sarcomaoncology.com

Principal investigator and sarcoma expert Dr. Sant Chawla presents the results of the phase 2b clinical trial comparing the drugs Aldoxrubicin and Doxorubicin in patients with advanced soft tissue sarcomas at the 2014 ASCO Annual Meeting.

To learn more about sarcoma clinical trials, contact Dr. Chawla at the Sarcoma Oncology Center in Santa Monica at (310) 552-9999.